Shanghai Pharmaceuticals Holding Co., Ltd (2607.HK)
HKD 13.06
(-0.61%)
HKD 13.06
(-0.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.23 Billion | 4.74 Billion | 5.06 Billion | 6.84 Billion | 6.02 Billion | 3.13 Billion |
| Net Income | 5.16 Billion | 6.99 Billion | 6.27 Billion | 5.6 Billion | 4.83 Billion | 4.45 Billion |
| Depreciation & Amortization | 2.18 Billion | 2.22 Billion | 2.13 Billion | 2.13 Billion | 1.88 Billion | 1.16 Billion |
| Deferred income taxes | -4.56 Million | -21.99 Million | -31.33 Million | -34.74 Million | -1.23 Million | - |
| Stock-based compensation | 4.56 Million | 21.99 Million | 31.33 Million | 34.74 Million | 1.23 Million | - |
| Change in working capital | -4.34 Billion | -4.68 Billion | -3.39 Billion | -2.01 Billion | -2.57 Billion | -3.71 Billion |
| Other non-cash items | 2.22 Billion | 208.91 Million | 45.6 Million | 1.11 Billion | 1.87 Billion | 1.22 Billion |
| Investing Cash Flow | -2.49 Billion | -12.47 Billion | -6.01 Billion | -1.7 Billion | -4.58 Billion | -7.69 Billion |
| Investments in PPE | -2.97 Billion | -2.68 Billion | -4.11 Billion | -3 Billion | -2.75 Billion | -1.94 Billion |
| Acquisitions | -356.57 Million | 22.46 Million | -1.03 Billion | -2.04 Billion | -693.68 Million | -5.19 Billion |
| Investment purchases | -27.37 Billion | -39.68 Billion | -3.14 Billion | -4.49 Billion | -1.04 Billion | -1.04 Billion |
| Sales/Maturities of investments | 27.86 Billion | 30.26 Billion | 3.28 Billion | 4.8 Billion | 1.27 Billion | 1.33 Billion |
| Other Investing Activities | 350.56 Million | -394.02 Million | -997.83 Million | 3.03 Billion | -1.36 Billion | -836.41 Million |
| Financing Cash Flow | 231.85 Million | 12.13 Billion | 1.56 Billion | -1.26 Billion | -2.32 Billion | 7.52 Billion |
| Debt repayment | -72.33 Billion | -59.8 Billion | -52.21 Billion | -47.57 Billion | -1.08 Billion | -53.2 Billion |
| Dividends payments | -3.98 Billion | -3.09 Billion | -2.67 Billion | -2.41 Billion | -2.58 Billion | -2.35 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 2.62 Billion |
| Other Financing Activities | -1.7 Billion | 75.04 Billion | 56.45 Billion | 48.73 Billion | -822.33 Million | 60.46 Billion |
| Accounts receivables | -6.43 Billion | -10.08 Billion | -6.15 Billion | -4.07 Billion | -5.08 Billion | -2.18 Billion |
| Accounts payables | 6.43 Billion | 10.08 Billion | 6.15 Billion | 4.07 Billion | 5.08 Billion | - |
| Inventory | -2.3 Billion | -7.11 Billion | -3.2 Billion | 932.6 Million | 63.14 Million | -2.84 Billion |
| Other working capital | -2.04 Billion | 2.43 Billion | -197.69 Million | -2.94 Billion | -2.63 Billion | -868.75 Million |
| Cash at beginning of period | 24.53 Billion | 20.13 Billion | 19.57 Billion | 15.71 Billion | 16.6 Billion | 13.56 Billion |
| Cash at end of period | 27.49 Billion | 24.53 Billion | 20.13 Billion | 19.57 Billion | 15.71 Billion | 16.6 Billion |
| Capital Expenditure | -2.97 Billion | -2.68 Billion | -4.11 Billion | -3 Billion | -2.75 Billion | -1.94 Billion |
| Effect of forex changes on cash | -5.58 Million | -12.44 Million | -50.32 Million | -17.62 Million | -1.6 Million | 67.44 Million |
| Net cash flow / Change in cash | 2.96 Billion | 4.39 Billion | 561.05 Million | 3.86 Billion | -889.29 Million | 3.03 Billion |
| Free Cash Flow | 2.26 Billion | 2.05 Billion | 942.55 Million | 3.83 Billion | 3.26 Billion | 1.19 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 1.39 Billion | 1.54 Billion | 5.16 Billion | -28.77 Million | 1.18 Billion |
| Depreciation & Amortization | - | 1.24 Billion | - | 2.18 Billion | 2.02 Billion | -999.9 Million |
| Deferred income taxes | - | - | - | -4.56 Million | 7.00 | -9.08 Billion |
| Stock-based compensation | - | 350.2 Thousand | - | 4.56 Million | 4.56 Million | -2.52 Million |
| Change in working capital | - | -6.53 Billion | - | -4.34 Billion | -8.73 Billion | 9.08 Billion |
| Other non-cash items | - | 9.87 Billion | -7.01 Billion | 2.22 Billion | 9.66 Billion | 476.98 Million |
| Investing Cash Flow | -1.67 Billion | 191.44 Million | 1.84 Billion | -2.49 Billion | 507.67 Million | -384.89 Million |
| Investments in PPE | -442.09 Million | -521.57 Million | -871.61 Million | -2.97 Billion | -685.99 Million | -780.88 Million |
| Acquisitions | 2.18 Million | -90.98 Million | 7.47 Million | -356.57 Million | -199.82 Million | -5.77 Million |
| Investment purchases | -7.45 Billion | -1.3 Billion | -7.1 Billion | -27.37 Billion | -2 Billion | -11.05 Billion |
| Sales/Maturities of investments | 6.37 Billion | 1.88 Billion | 10.17 Billion | 27.86 Billion | 3.56 Billion | 11.43 Billion |
| Other Investing Activities | -152 Million | 85.26 Million | -365.84 Million | 350.56 Million | -175.22 Million | 18.17 Million |
| Financing Cash Flow | -3.62 Billion | 512.84 Million | 3.25 Billion | 231.85 Million | -2.56 Billion | -2.33 Billion |
| Debt repayment | -1.8 Billion | -1.75 Billion | -4.02 Billion | -72.33 Billion | -21.83 Billion | -12.1 Billion |
| Dividends payments | -2.16 Billion | -392.56 Million | -559.22 Million | -3.98 Billion | -333.88 Million | -2.73 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 346.99 Million | -794.45 Million | -113.39 Million | -1.7 Billion | -537.88 Million | 12.5 Billion |
| Accounts receivables | - | -7.86 Billion | - | -6.43 Billion | -6.43 Billion | 10.54 Billion |
| Accounts payables | - | - | - | 6.43 Billion | - | - |
| Inventory | - | 1.33 Billion | - | -2.3 Billion | -2.3 Billion | -1.45 Billion |
| Other working capital | - | - | - | -2.04 Billion | - | - |
| Cash at beginning of period | 33.8 Billion | 27.12 Billion | 27.49 Billion | 24.53 Billion | 26.57 Billion | 28.68 Billion |
| Cash at end of period | 30.75 Billion | 33.8 Billion | 27.12 Billion | 27.49 Billion | 27.49 Billion | 26.57 Billion |
| Capital Expenditure | -442.09 Million | -521.57 Million | -871.61 Million | -2.97 Billion | -685.99 Million | -780.88 Million |
| Effect of forex changes on cash | -14.68 Million | -15.92 Million | 7.73 Million | -5.58 Million | 55.26 Million | -59.89 Million |
| Net cash flow / Change in cash | -3.04 Billion | 6.67 Billion | -373.87 Million | 2.96 Billion | 927.9 Million | -2.11 Billion |
| Free Cash Flow | -442.09 Million | 5.46 Billion | -6.34 Billion | 2.26 Billion | 2.24 Billion | -116.84 Million |
ONXXF
0YXG
TFAS
TSYHF
600698
0L9Q